Efavirenz Suppliers & Bulk Manufacturers
Available Forms: Tablet & Capsule
Available Strengths: Tab: 200 mg, 600 mg; Cap: 50 mg, 100 mg, 200 mg
Reference Brands: Sustiva®(US); Stocrin®(EU)
Category: Anti Viral
Efavirenz Tablets, a key NNRTI for HIV treatment, are available in 200 mg and 600 mg strengths. PharmaB2B connects global buyers with certified manufacturers offering bulk supply and fixed-dose combos like Atripla. Ideal for compliant sourcing in tenders, HIV programs, and international pharmaceutical trade. Efavirenz is available in Tablet & Capsule and strengths such as Tab: 200 mg, 600 mg; Cap: 50 mg, 100 mg, 200 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Efavirenz is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Efavirenz can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Efavirenz Tablets are widely used as part of combination therapy for HIV-1 treatment, classified under NNRTIs. Commonly available in 600 mg and pediatric strengths, Efavirenz is also found in fixed-dose combinations like Atripla®. On PharmaB2B platforms, bulk buyers and distributors can connect with GMP-certified manufacturers for high-quality Efavirenz products. Ideal for hospitals, HIV programs, NGOs, and government tenders, PharmaB2B supports cost-effective and compliant procurement across global markets. Whether sourcing single or combo formulations, buyers benefit from reliable supply chains and competitive pricing. Choose PharmaB2B for trusted suppliers of Efavirenz and other essential antiretrovirals.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Efavirenz is used to treat HIV-1 infection. It helps reduce viral load and improve immune function by blocking the HIV reverse transcriptase enzyme. It is typically used as part of combination antiretroviral therapy.
Efavirenz is made from the active non-nucleoside reverse transcriptase inhibitor (NNRTI) compound efavirenz, a synthetic benzoxazinone derivative.
The well-known trade name is Sustiva.
Sustiva is manufactured by Bristol-Myers Squibb (BMS). Many generic pharmaceutical companies worldwide also produce efavirenz.
The generic name is efavirenz.
The primary brand name is Sustiva.
Efavirenz is manufactured in approved facilities across the USA, Europe, and India, depending on whether it is the innovator brand or a generic version.
Related Products
Maraviroc
Strength:
150 mg, 300 mg, 20 mg
Form: Tablets / Oral solution
Reference Brands: Selzentry (USA), Celsentri (EU)
View Details
Raltegravir
Strength:
100mg, 400 mg, 600mg
Form: Tablets
Reference Brands: Isentress (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
